Cognition Therapeutics Inc
CGTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001455365
No open-market purchases or sales by Cognition Therapeutics Inc insiders were filed in the last 90 days; 66 institutions reported holding it in 13F filings for Q2 2026, worth $26.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Cognition Therapeutics Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +7 vs. Q4 2021
- Shares held
- 1.67M
- +333.2K (+25.0%) vs. Q4 2021
- Total value
- $4.58M
- −$3.86M (−45.7%) vs. Q4 2021
- New holders
- 11
- 4 more added
- Sold out
- 4
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $26.0M |
| Q1 2026 | 75 | $16.3M |
| Q4 2025 | 78 | $28.9M |
| Q3 2025 | 68 | $28.7M |
| Q2 2025 | 48 | $3.50M |
| Q1 2025 | 51 | $4.89M |
| Q4 2024 | 45 | $7.78M |
| Q3 2024 | 40 | $1.99M |
| Q2 2024 | 46 | $8.82M |
| Q1 2024 | 47 | $12.9M |
| Q4 2023 | 37 | $13.2M |
| Q3 2023 | 36 | $10.4M |
| Q2 2023 | 35 | $13.0M |
| Q1 2023 | 32 | $14.1M |
| Q4 2022 | 34 | $10.1M |
| Q3 2022 | 31 | $9.67M |
| Q2 2022 | 28 | $11.4M |
| Q1 2022 | 27 | $4.58M |
| Q4 2021 | 20 | $8.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Cognition Therapeutics Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prosight Management, LP | 240,080 | $660.0K | 0.46% | −61,899−20.5% | Reduced |
| Kestra Advisory Services, LLC | 238,666 | $656.0K | 0.01% | +143,554+150.9% | Added |
| American Financial Group Inc | 205,000 | $564.0K | 0.17% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 196,402 | $540.0K | 0.04% | −13,186−6.3% | Reduced |
| Worth Venture Partners, LLC | 175,366 | $473.0K | 0.22% | +175,366 | New |
| P.A.W. Capital Corp | 120,000 | $330.0K | 0.34% | +20,000+20.0% | Added |
| Bridgeway Capital Management, LLC | 76,200 | $206.0K | 0.00% | +76,200 | New |
| Vanguard Group Inc | 58,596 | $161.0K | 0.00% | +170.0% | Added |
| Frontier Wealth Management LLC | 50,000 | $152.0K | 0.00% | +50,000 | New |
| Two Sigma Investments, LP | 42,102 | $116.0K | 0.00% | −41,296−49.5% | Reduced |
| B. Riley Financial, Inc. | 30,904 | $85.0K | 0.01% | 00.0% | Unchanged |
| Diligent Investors, LLC | 30,520 | $84.0K | 0.02% | +30,520 | New |
| Two Sigma Advisers, LP | 28,100 | $77.0K | 0.00% | −40,800−59.2% | Reduced |
| Rock Creek Group, LP | 26,439 | $71.0K | 0.01% | 00.0% | Unchanged |
| Voss Capital, LLC | 26,439 | $71.0K | 0.02% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 20,393 | $56.0K | 0.00% | +20,393 | New |
| Bangor Savings Bank | 18,496 | $51.0K | 0.01% | +18,496 | New |
| New York Life Investments Alternatives | 17,667 | $49.0K | 0.03% | −5,024−22.1% | Reduced |
| Millennium Management LLC | 14,536 | $39.0K | 0.00% | −41,883−74.2% | Reduced |
| Commonwealth Equity Services, LLC | 13,890 | $38.0K | 0.00% | +13,890 | New |
| Geode Capital Management, LLC | 13,726 | $37.0K | 0.00% | +13,726 | New |
| Citadel Advisors LLC | 10,504 | $28.0K | 0.00% | +10,504 | New |
| BlackRock Inc. | 8,285 | $23.0K | 0.00% | +288+3.6% | Added |
| UBS Group AG | 3,749 | $10.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 434 | $1.00K | 0.00% | +434 | New |
| Wells Fargo & Company | 24 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1,500 | – | – | +1,500 | New |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −25,496−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,764−100.0% | Sold out |
| Bray Capital Advisors | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |